Clostridium difficile infection

Annual Review of Medicine

Volumn 49, Issue , 1998, Pages 375-390

  Kelly, Ciarán P ^a   LaMont, J Thomas ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Antibiotic; Colitis; Diarrhea; Pseudomembranous colitis; Toxin

Indexed keywords

ANTIBIOTIC AGENT; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; EXOTOXIN; METRONIDAZOLE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CLOSTRIDIUM DIFFICILE; COLON MUCOSA; DIARRHEA; DRUG WITHDRAWAL; FECES ANALYSIS; HOSPITAL INFECTION; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS; RELAPSE; REVIEW;

ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; COLON; DIARRHEA; DRUG COSTS; DRUG RESISTANCE, MICROBIAL; ENTEROCOLITIS, PSEUDOMEMBRANOUS; EXOTOXINS; FECES; HOSPITALIZATION; HUMANS; INTESTINAL MUCOSA; METRONIDAZOLE; RECURRENCE; TIME FACTORS; VANCOMYCIN;

EID: 0031958706     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.49.1.375     Document Type: Review

References (16)

1. Hall IC, O'Toole E. 1935. Intestinal flora in newborn infants with description of a new pathogenic anaerobe. Am. J. Dis. Child 49:390-402
2. Tedcsco FJ, Barton RW, Alpers DH. 1974. Clindamycin-associated colitis. A prospective study. Ann. Intern. Med. 81: 429-33
3. Bartlett JG, Chang TW, Gurwith M, et al. 1978. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N. Engl. J. Med. 298:531-34
4. Larson HE, Price AB, Honour P, Borriello SP. 1978. Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet 1:1063-66
5. Kelly CP, Pothoulakis C, LaMont JT. 1994. Clostridium difficile colitis. N. Engl. J. Med. 330:257-62
6. Linevsky JK, Kelly CP. 1997. Clostridium difficile colitis. In Gastrointestinal Infections: Diagnosis and Management, ed. JT LaMont, pp. 293-325. New York: Marcel Dekker
7. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. 1989. Nosocomial acquisition of Clostridium difficile infection. N. Engl. J. Med. 320:204-10
8. Johnson S, Clabots CR, Linn FV, et al. 1990. Nosocomial Clostridium difficile colonisation and disease. Lancet 336: 97-100
9. Fekety R, Kim KH, Brown D, et al. 1981. Epidemiology of antibiotic-associated colitis; isolation of Clostridium difficile from the hospital environment. Am. J. Med. 70:906-8
10. Kim KH, Fekety R, Batts DH, et al. 1981. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J. Infect. Dis. 143:42-50
11. Borriello SP. 1990. The influence of the normal flora on Clostridium difficile colonisation of the gut. Ann. Med. 22:61-67
12. Tvede M, Rask-Madsen J. 1989. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet 1:1156-60
13. Saginur R, Hawley CR, Bartlett JG. 1980. Colitis associated with metronidazole therapy. J. Infect. Dis. 141:772-74
14. Thomson G, Clark AH, Hare K, Spilg WG. 1981. Pseudomembranous colitis after treatment with metronidazole. Br. Med. J. 282:864-65
15. Viscidi R, Willey V, Bartlett JG. 1981. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology 81:5-9
16. Barroso LA, Wang SZ, Phelps CJ, et al. 1990. Nucleotide sequence of Clostridium difficile toxin B gene. Nucleic Acids Res. 18:4004